Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension
Download in electronic PDF format for $75
Abstract: The purpose of this article is to provide the compounding pharmacist with an overview of two ocular diseases that commonly affect cats and to describe the medications used in therapy. The author discusses feline herpesvirus-1 and systemic hypertension. A table provides selected drug therapies for feline conjunctivitis and keratitis, and a sidebar provides information regarding quinolone-induced blindness. In summary, four of the seven therapies for treating feline herpesvirus-related conjunctivitis and keratitis are commercially unavailable; and the therapy for feline hypertension is appropriate only for human dosing, so compounded dosage forms must often be used. Understanding ocular pharmacology and the underlying causes of feline ophthalmic disease can help the compounding pharmacist become integrally involved in feline care and can contribute to positive therapeutic outcomes and an increased quality of life for the patient.
Related Keywords:
cat, eye disease, feline, feline conjunctivitis, feline herpesvirus, herpesvirus, keratitis, ophthalmic disease, systemic hypertension
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension
Davidson Michael G
|
Mar/Apr 2001
Pg. 92-94
|
The Treatment of Canine Atopic Disease
Davidson Gigi S
|
May/Jun 2002
Pg. 210-215
|
Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
|
Jul/Aug 2003
Pg. 288-291
|
Compounding for Feline Herpetic Keratitis
Davidson Gigi S
|
Nov/Dec 2006
Pg. 411-414
|
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin
Rudner Shara, Browne Paul
|
Nov/Dec 2010
Pg. 488-491
|
Treating Canine Hepatic Disease
Davidson Gigi S
|
May/Jun 2003
Pg. 188-191
|
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William, Helms Scott R
|
Sep/Oct 2008
Pg. 392-397
|
Feline Urologic Syndrome and Diet Formulation
Long Scott F
|
Sep/Oct 1999
Pg. 366-367
|
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1
Davidson Gigi S
|
May/Jun 2004
Pg. 169-172
|
Understanding Feline Hyperthyroidism
Davidson Gigi S
|
Sep/Oct 2003
Pg. 345-347
|
Psychotropic Medications in the Treatment of Feline Urine Spraying
Simpson Barbara Sherman, Vail Jane
|
Jan/Feb 2007
Pg. 44-48
|
Compounding Transdermal Medication for Feline Patients
Eichstadt Lauren R
|
Jul/Aug 2016
Pg. 271-274
|
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
|
Nov/Dec 2022
Pg. 468-472
|
Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists
Meadows Richard L, Muller George
|
Sep/Oct 2010
Pg. 382-394
|
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3
Davidson Gigi S
|
Sep/Oct 2004
Pg. 359-367
|
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease
McElhiney Linda F
|
May/Jun 2012
Pg. 190-195
|
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Helms Scott R, Fox Samantha, Mixon William, Vail Jane
|
Jan/Feb 2012
Pg. 34-41
|
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
|
Jan/Feb 2010
Pg. 40-45
|
Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety
Fields Shannon W
|
Nov/Dec 2006
Pg. 418
|
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2
Davidson Gigi S
|
Jul/Aug 2004
Pg. 277-283
|
| Return to Top |
